Compare · DHR vs MASS
DHR vs MASS
Side-by-side comparison of Danaher Corporation (DHR) and 908 Devices Inc. (MASS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DHR and MASS operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- DHR is the larger of the two at $123.97B, about 486.1x MASS ($255.0M).
- DHR has been more active in the news (20 items in the past 4 weeks vs 11 for MASS).
- DHR has more recent analyst coverage (25 ratings vs 5 for MASS).
- Company
- Danaher Corporation
- 908 Devices Inc.
- Price
- $175.13-2.12%
- $6.81-0.15%
- Market cap
- $123.97B
- $255.0M
- 1M return
- -
- +9.66%
- 1Y return
- -
- +21.39%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 20
- 11
- Recent ratings
- 25
- 5
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
908 Devices Inc.
908 Devices Inc. develops and sells measurement devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and the Asia Pacific. It offers handheld and desktop mass spectrometry (Mass Spec) devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Latest DHR
- SEC Form CERT filed by Danaher Corporation
- SEC Form 8-A12B filed by Danaher Corporation
- SEC Form 8-K filed by Danaher Corporation
- Why Medtech Giants Are Quietly Paying Up for AI Diagnostics
- SEC Form 4 filed by Director Sanders A Shane
- SEC Form 4 filed by Director Stevens Raymond C
- SEC Form 4 filed by Director List Teri
- SEC Form 4 filed by Director Zerhouni Elias A.
- SEC Form 4 filed by Director Dewan Feroz
- SEC Form 4 filed by Director Filler Linda
Latest MASS
- 908 Devices to Report First Quarter 2026 Financial Results on May 6, 2026
- SEC Form 4 filed by SVP, Sales & Product Marketing Kenneweg John
- SEC Form DEFA14A filed by 908 Devices Inc.
- SEC Form DEF 14A filed by 908 Devices Inc.
- SEC Form 4 filed by Otitoju Kolawole A.
- SEC Form 3 filed by new insider Otitoju Kolawole A.
- 908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SEC Form 4 filed by Mccallion Kevin J.
- SEC Form 4 filed by Mccallion Kevin J.
- SEC Form 4 filed by Brown Christopher D.